These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.

View All HCPCS Sections

• J2562

  Injection, plerixafor, 1 mg

• J2590

  Injection, oxytocin, up to 10 units

• J2596

  Injection, vasopressin (long grove), not therapeutically equivalent to j2598, 1 unit

• J2597

  Injection, desmopressin acetate, per 1 mcg

• J2598

  Injection, vasopressin, 1 unit

• J2599

  Injection, vasopressin (american regent), not therapeutically equivalent to j2598, 1 unit

• J2601

  Injection, vasopressin (baxter), 1 unit

• J2650

  Injection, prednisolone acetate, up to 1 ml

• J2670

  Injection, tolazoline hcl, up to 25 mg

• J2675

  Injection, progesterone, per 50 mg

• J2679

  Injection, fluphenazine hcl, 1.25 mg

• J2680

  Injection, fluphenazine decanoate, up to 25 mg

• J2690

  Injection, procainamide hcl, up to 1 gm

• J2700

  Injection, oxacillin sodium, up to 250 mg

• J2704

  Injection, propofol, 10 mg

• J2710

  Injection, neostigmine methylsulfate, up to 0.5 mg

• J2711

  Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg

• J2720

  Injection, protamine sulfate, per 10 mg

• J2724

  Injection, protein c concentrate, intravenous, human, 10 iu

• J2725

  Injection, protirelin, per 250 mcg

• J2730

  Injection, pralidoxime chloride, up to 1 gm

• J2760

  Injection, phentolamine mesylate, up to 5 mg

• J2765

  Injection, metoclopramide hcl, up to 10 mg

• J2770

  Injection, quinupristin/dalfopristin, 500 mg (150/350)

• J2777

  Injection, faricimab-svoa, 0.1 mg

• J2778

  Injection, ranibizumab, 0.1 mg

• J2779

  Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg

• J2780

  Injection, ranitidine hydrochloride, 25 mg

• J2781

  Injection, pegcetacoplan, intravitreal, 1 mg

• J2782

  Injection, avacincaptad pegol, 0.1 mg

• J2783

  Injection, rasburicase, 0.5 mg

• J2785

  Injection, regadenoson, 0.1 mg

• J2786

  Injection, reslizumab, 1 mg

• J2787

  Riboflavin 5'-phosphate, ophthalmic solution, up to 3 ml

• J2788

  Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)

• J2790

  Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)

• J2791

  Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu

• J2792

  Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu

• J2793

  Injection, rilonacept, 1 mg

• J2794

  Injection, risperidone (risperdal consta), 0.5 mg

• J2795

  Injection, ropivacaine hydrochloride, 1 mg

• J2796

  Injection, romiplostim, 10 micrograms

• J2797

  Injection, rolapitant, 0.5 mg

• J2798

  Injection, risperidone, (perseris), 0.5 mg

• J2799

  Injection, risperidone (uzedy), 1 mg

• J2800

  Injection, methocarbamol, up to 10 ml

• J2801

  Injection, risperidone (rykindo), 0.5 mg

• J2802

  Injection, romiplostim, 1 microgram

• J2804

  Injection, rifampin, 1 mg

• J2805

  Injection, sincalide, 5 micrograms

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/4/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.